Alnylam Pharmaceuticals
ALNY
#650
Rank
NZ$65.69 B
Marketcap
NZ$492.08
Share price
-2.20%
Change (1 day)
-0.74%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company